News Acacia Pharma stock market launch to support nausea products Acacia Pharma is to raise new funds through an initial global offering and launch on to the Euronext Brussels stock exchange
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.